Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Population Pharmacokinetics
100%
Bootstrap
100%
Pemetrexed
100%
Asian Patients
100%
Volume of Distribution
66%
Coefficient of Variation
66%
Sex Effect
66%
Covariate Modelling
66%
Confidence Interval
33%
Clinically Significant
33%
Plasma Samples
33%
Pharmacokinetic Parameters
33%
Body Surface Area
33%
Maximum Permissible Concentration
33%
Albumin
33%
Final Model
33%
NONMEM
33%
Population Pharmacokinetic Model
33%
Creatinine Clearance
33%
Between-subject Variability
33%
Model Qualification
33%
Parameter Estimation
33%
Population Parameters
33%
Effect Parameter
33%
Population Pharmacokinetic Analysis
33%
Bayesian Credible Interval
33%
Expectation-maximization Algorithm
33%
Credible Interval
33%
Intravenous Infusion
33%
Diagnostic Plot
33%
Stochastic Approximation Expectation Maximization
33%
Relative Standard Error
33%
Visual Predictive Check
33%
Markov Chain Monte Carlo Bayesian Analysis
33%
Mathematics
Covariate
100%
Null
66%
Parameter Estimate
66%
Model Covariates
66%
Credible Interval
66%
Confidence Interval
33%
Subject Variability
33%
Stochastics
33%
Population Parameter
33%
Bayesian
33%
Final Model
33%
Bayesian Analysis
33%
Diagnostic Plot
33%
Markov Chain Monte Carlo
33%
Medicine and Dentistry
Pharmacokinetics
100%
Lung Cancer
100%
Pemetrexed
100%
Bootstrapping
75%
Volume of Distribution
50%
Body Surface
25%
Diagnosis
25%
Intravenous Drug Administration
25%
Creatinine Clearance
25%
NONMEM
25%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Pemetrexed
100%
Pharmacokinetics
100%
Volume of Distribution
66%
Pharmacokinetic Parameter
33%
Creatinine
33%
NONMEM
33%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
100%
Pemetrexed
100%
Blood Plasma
50%
Surface Area
25%
Pharmacokinetic Modeling Software
25%
Creatinine Clearance
25%
Neuroscience
Pemetrexed
100%
Pharmacokinetics
100%
Blood Plasma
50%
Creatinine
25%